-
Solomons PM survives attempt to oust government
-
Tech firms rally on mixed day for Asian markets, with eyes on US inflation
-
Ohtani 'unlikely' to pitch again this season, says Dodgers manager
-
World number one An sends Asian Games warning with China hat-trick
-
Driver thanks 'superhero' rival for saving him from flaming race car
-
PSG go for three in a row as Champions League returns
-
Can dogs sniff cancer? AI joins the hunt in India
-
"Super-human' Alcaraz books US Open quarter-final clash with Shelton
-
Shelton steams into US Open quarter-final clash with Alcaraz
-
ECB set to hike interest rates as Iran war flares anew
-
25 years on, America seeks to keep 9/11 memories alive
-
AI data centers are less thirsty now, tech giants say
-
'Trumpapalooza' tests Republican bet on unpopular US president
-
North Korea vows nuclear-armed navy as US ally drills open
-
Pegula tops Cirstea to reach US Open quarter-finals
-
Under-fire Labuschagne named in Australia Test squad for South Africa
-
Australians could opt out of social media algorithms under new law
-
Enjoying the moment: Alcaraz steps it up to reach US Open quarter-finals
-
Tiafoe tops Medvedev in straight sets at US Open
-
Five dead, five injured after Amazon cargo plane overshoots Miami runway
-
Zverev seeks US Open last eight as Osaka faces Rybakina
-
La Rochelle half-backs lead fightback against Toulouse
-
Alcaraz turns up heat to reach US Open quarters
-
US envoys have 'more effective proposals': Ukraine official
-
Gatti salvages Juve draw with AC Milan in Serie A
-
Defending champion Alcaraz powers into US Open quarter-finals
-
Sinayoko stars as unbeaten Paris FC down Marseille
-
Amazon cargo plane overshoots Miami runway, hits vehicles, catches fire
-
Still on top: 'Spider-Man' dominates North American box office
-
Toll from Yemen clashes passes 300 as civilians flee homes
-
Zelensky in fresh talks with US envoys: Ukraine official
-
Sabalenka books US Open quarter-final clash with Noskova
-
Noskova edges Kostyuk to reach US Open quarter-finals
-
German AfD supporters jubilant at far right's thumping win
-
Alonso urges Chelsea to learn from painful defeat at Arsenal
-
Zelensky warns war likely to continue into winter after US talks
-
Defending champion Sabalenka reaches US Open quarter-finals
-
Arsenal deliver statement fightback to end Chelsea's flying start
-
Minnows Augsburg sink Frankfurt to top Bundesliga table
-
Leclerc accepts blame as Hamilton laments Ferrari approach
-
Yamal hits double as 'nearly perfect' Barca thrash Valencia
-
Sabalenka surges past Townsend to reach US Open quarter-finals
-
Antonelli living 'a dream' after astonishing home win
-
Smiling face of Germany's far-right AfD: Ulrich Siegmund
-
Impressive Daryz keeps Arc double dream alive
-
Lebanon president calls for US help as Israeli strikes kill 7
-
Strasbourg hit Troyes for six as Amo-Ameyaw sparkles
-
Yamal hits double as perfect Barca thrash Valencia
-
German far-right AfD landslide winner in eastern state vote
-
Venice festival turns gaze on war reporters, media industry
NDT Pharmaceuticals' Good Salt(TM) Life Subsidiary Unveils Scalable Antimicrobial Platform to Drive Health, Safety, and Sustainability Across Global Markets
ATHENS, GEORGIA / ACCESS Newswire / September 23, 2025 / Good Salt™ Life, Inc., a wholly owned subsidiary of NDT Pharmaceuticals Inc. (OTCID:NDTP) ("NDTP" or the "Company"), today shared insight into its strategic initiative designed to build value through investments in sustainable, science-driven health and wellness brands that protect people, pets, and the planet. Good Salt Life targets the $148 billion global biosafety market with a vertically integrated approach that combines proprietary hardware and EPA-approved antimicrobial solutions.
At the heart of Good Salt Life's innovation is hypochlorous acid (HOCl), a naturally occurring substance produced by the human body to combat infection. Through proprietary electrolysis, Good Salt Life transforms salt and water into powerful, eco-friendly solutions for home care, pet wellness, skincare, and professional biosafety. The Company's products are non-toxic, family-safe, and environmentally conscious, meeting the highest performance standards backed by EPA registration and rigorous third-party testing.
Trusted by Industry Leaders
Good Salt Life's breakthrough technologies have earned the trust of leading organizations across multiple sectors, including:
Animal Health: Strengthening welfare and biosecurity outcomes in critical environments to reduce mortality and ensure human health.
Cruise Industry: Partnering with industry giants such as Virgin, Royal Caribbean, Carnival Corp, and Norwegian Cruise Line to establish new benchmarks for passenger health and safety at sea.
Education & Healthcare: Providing solutions to renowned institutions like the Baptist Hospital System and Cleveland Clinic, ensuring the safety of vulnerable populations in hospitals and schools.
Government & Nonprofits: Offering proven solutions for maintaining hygiene in the Tennessee State Prison System, NY State Prison, New York City Fire Department, and Ronald McDonald House.
Sports: Collaborating with the New York Yankees, Boston Red Sox, Tampa Bay Rays, and NCAA programs including Ole Miss, Alabama, Clemson, LSU, and WKU Football to enhance safety and health standards.
Retail and E-Commerce: Expanding reach through partnerships with major distributors such as Amazon, Chewy, Walmart, Staples, Ecolox Tech, Imperial Dade, Veritiv, and System Chemical, making innovative products accessible to consumers.
Driving Scalable Impact
From households to large institutions, Good Salt Life's solutions are reshaping the meaning of cleanliness and protection. Whether reducing pathogens in animal shelters, safeguarding healthcare workers on the frontlines, or ensuring cruise passengers travel with peace of mind, Good Salt Life is scaling across markets where safety and sustainability are essential.
Investing in the Future
Good Salt Life is also focused on next-generation technologies that extend beyond chemistry. With advancements in robotics, AI-driven automation, and pioneering indoor air quality sensors, Good Salt Life is building a holistic ecosystem of safety solutions. These innovations will reduce labor costs, improve efficiency, and provide proactive protection against emerging health risks.
Commitment to Responsibility
"Good Salt Life stands at the intersection of innovation and responsibility," said Zach O'Shea, President and CEO of NDT Pharmaceuticals. "We are not just creating products; we are building a platform for healthier living, animal welfare, and environmental stewardship. As we grow alongside world-class partners and distributors, our vision remains clear: to lead the global shift toward safer, cleaner, and more sustainable living for future generations."
About NDT Pharmaceuticals, Inc. (OTC:NDTP)
NDT Pharmaceuticals, Inc. (OTC:NDTP) is a publicly traded company focused on advancing innovative consumer health and wellness solutions. With its recent acquisition of Good Salt Life Inc., NDTP has expanded its strategic direction into sustainable, science-driven products that promote healthier living. The Company is committed to building value through investments in brands that protect people, pets, and the planet while aligning with growing consumer demand for eco-friendly and health-conscious alternatives.
About Good Salt Life, Inc.
Good Salt Life is dedicated to promoting vitality through eco-friendly, nature-derived products that support healthier living environments. With a focus on innovation and sustainability, the company offers safe and effective solutions for home, pet, personal care, and animal health. Through strategic partnerships, including collaborations in the B2B animal health sector, Good Salt Life continues to drive advancements that benefit both people and animals. For more information, visit www.goodsaltlife.com.
Forward-Looking Statements
This press release contains forward-looking statements, as that term is defined in the Private Litigation Reform Act of 1995, that involve significant risks and uncertainties. Forward-looking statements can be identified through the use of words such as "may," "might," "will," "intend," "should," "could," "can," "would," "continue," "expect," "believe," "anticipate," "estimate," "predict," "outlook," "potential," "plan," "seek," and similar expressions and variations or the negatives of these terms or other comparable terminology. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect the Company's current expectations and speak only as of the date of this release. Actual results may differ materially from the Company's current expectations. Except as required by law, the Company does not undertake any responsibility to revise or update any forward-looking statements.
Contact:
SOURCE: NDT Pharmaceuticals Inc.
View the original press release on ACCESS Newswire
A.Malone--AMWN